David A. Roth

David A. Roth, PhD is a founder of Multimeric who has extensive biotech management experience, including product and business development and research operations experience. He was most recently Senior Director – Research Operations at Halozyme Therapeutics, Inc. where he directed teams that generated several registered products. Prior to that, David was Senior Vice President for R&D at CODA Genomics (subsequently Verdezyne, Inc.). He is the author of 36 papers and 17 patents. Dr. Roth received his B.S., M.S., and Ph.D. degrees from the University of California at Berkeley, and took postdoctoral training at the UCSD School of Medicine.